BSX in the 13F filings
Boston Scientific Corp · CUSIP 101137107
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 10 May 2024
- Managers listing it
- 33
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 29 listed it in both
- Shares listed
- 350,819,421
- combined, among listed positions
- Reported value
- $24.0bn
- combined, at the quarter end
1 line marked †. Value as filed implies a price far from other filers'. Each counts in holders and value as filed, and is left out of the net change in shares.
Among the 93 comparable managers: 13 buyers (opened or added shares) and 19 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing BSX in Q1 2024
33 of 33 holders
Largest increases and reductions, by shares
Increases
- Capital World Investorsexisting position · 16,008,085 shares now+6,588,256
- Fidelity (FMR LLC)existing position · 141,930,013 shares now+3,679,063
- Capital Research Global Investorsnew position · 2,670,426 shares now+2,670,426
- Millennium Management LLCexisting position · 9,479,667 shares now+2,111,388
- Marshall Wace LLPexisting position · 3,112,322 shares now+1,495,021
Reductions
- MFS Investment Managementexisting position · 46,607,016 shares now-10,568,954
- Wellington Management Group LLPexisting position · 33,288,817 shares now-3,152,310
- Point72 Asset Management LPexisting position · 2,366,189 shares now-2,344,656
- Holocene Advisors LPexisting position · 5,787,999 shares now-2,097,160
- Farallon Capital Management LLCexisting position · 4,596,657 shares now-1,223,600
New positions and exits
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 13 | $3.9bn | n.a. | n.a. |
| Q3 2013 | 17 | $5.3bn | n.a. | n.a. |
| Q4 2013 | 15 | $4.8bn | n.a. | n.a. |
| Q1 2014 | 12 | $5.6bn | n.a. | n.a. |
| Q2 2014 | 15 | $5.1bn | n.a. | n.a. |
| Q3 2014 | 21 | $5.1bn | n.a. | n.a. |
| Q4 2014 | 16 | $5.3bn | n.a. | n.a. |
| Q1 2015 | 18 | $6.7bn | n.a. | n.a. |
| Q2 2015 | 19 | $6.9bn | n.a. | n.a. |
| Q3 2015 | 19 | $6.8bn | n.a. | n.a. |
| Q4 2015 | 20 | $7.4bn | n.a. | n.a. |
| Q1 2016 | 17 | $8.3bn | n.a. | n.a. |
| Q2 2016 | 24 | $10.6bn | n.a. | n.a. |
| Q3 2016 | 26 | $10.4bn | n.a. | n.a. |
| Q4 2016 | 25 | $9.2bn | n.a. | n.a. |
| Q1 2017 | 23 | $11.1bn | n.a. | n.a. |
| Q2 2017 | 26 | $12.7bn | n.a. | n.a. |
| Q3 2017 | 24 | $13.4bn | n.a. | n.a. |
| Q4 2017 | 30 | $11.5bn | n.a. | n.a. |
| Q1 2018 | 32 | $12.4bn | n.a. | n.a. |
| Q2 2018 | 25 | $15.3bn | n.a. | n.a. |
| Q3 2018 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2018 | 28 | $16.2bn | n.a. | n.a. |
| Q1 2019 | 31 | $16.9bn | n.a. | n.a. |
| Q2 2019 | 23 | $19.2bn | n.a. | n.a. |
| Q3 2019 | 23 | $18.2bn | n.a. | n.a. |
| Q4 2019 | 26 | $19.7bn | n.a. | n.a. |
| Q1 2020 | 31 | $13.5bn | n.a. | n.a. |
| Q2 2020 | 29 | $14.1bn | n.a. | n.a. |
| Q3 2020 | 31 | $15.0bn | n.a. | n.a. |
| Q4 2020 | 35 | $13.6bn | n.a. | n.a. |
| Q1 2021 | 29 | $15.7bn | n.a. | n.a. |
| Q2 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q3 2021 | 27 | $18.2bn | n.a. | n.a. |
| Q4 2021 | 26 | $17.4bn | n.a. | n.a. |
| Q1 2022 | 32 | $17.4bn | n.a. | n.a. |
| Q2 2022 | 30 | $14.0bn | n.a. | n.a. |
| Q3 2022 | 29 | $14.5bn | n.a. | n.a. |
| Q4 2022 | 26 | $16.6bn | n.a. | n.a. |
| Q1 2023 | 32 | $18.5bn | n.a. | n.a. |
| Q2 2023 | 37 | $19.6bn | n.a. | n.a. |
| Q3 2023 | 33 | $19.7bn | n.a. | n.a. |
| Q4 2023 | 30 | $20.6bn | 14 | 19 |
| Q1 2024 | 33 | $24.0bn | 13 | 19 |
| Q2 2024 | 35 | $26.8bn | 21 | 15 |
| Q3 2024 | 40 | $28.3bn | 25 | 15 |
| Q4 2024 | 40 | $29.4bn | 18 | 21 |
| Q1 2025 | 44 | $33.1bn | 22 | 21 |
| Q2 2025 | 44 | $33.6bn | 24 | 21 |
| Q3 2025 | 48 | $29.5bn | 29 | 19 |
| Q4 2025 | 49 | $28.5bn | 28 | 22 |
| Q1 2026 | 45 | $17.2bn | 23 | 27 |
| Q2 2026 | 40 | $13.0bn | 30 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BSX and LLY →BSX and JNJ →BSX and VRTX →Choose a stock to compare with BSX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BSX, latest filings →Back to the 13F Explorer →